In a strategic pivot aimed at concentrating on markets offering greater growth potential and superior returns, building materials giant James Hardie Industries has announced a significant divestment, agreeing to sell its European Fermacell business to Swiss competitor Holcim for a substantial $980 million. This move signals a clear intention by James Hardie to streamline its operations and reallocate resources towards areas of the business projected to deliver higher profitability and expansion, marking a critical juncture in the company’s strategic roadmap.
Adapted from: WSJ.com: Markets
